Patent-in-Suit

News & Analysis as of

Shire LLC v. Amneal Pharms., LLC (D.N.J.)

The defendants include generic ANDA applicants (the “generic defendants”) and the API manufacturer, Johnson Matthey, Inc. and Johnson Matthey Pharmaceutical Materials (collectively “JM”). Six summary judgment motions were...more

Hoffmann-La Roche Inc. v. Apotex Inc. (Fed. Cir.)

Hoffman-La Roche (“Roche”) appeals from the decision of the district court granting defendants summary judgment of invalidity as to claims 1-8 of the ’634 patent and claims 1-10 of the ’957 patent. The asserted claims...more

Braintree Labs., Inc. v. Novel Labs., Inc. (Fed. Cir.)

Case Name: Braintree Labs., Inc. v. Novel Labs., Inc., 749 F.3d 1349 (Fed. Cir. Apr. 22, 2014) (Circuit Judges Dyk, Prost, and Moore presiding; Opinion by Prost, J.; Concurrence-in-part and Dissent by Dyk, J.; Dissent by...more

Motion to Stay Pending CBM Review Granted Where Non-Practicing Entity Did Not Seek Preliminary Injunction

Boku, Inc. ("Boku") filed a CBM petition with the PTAB seeking review of the patentability of Plaintiff's U.S. Patent No. 7,273,168 (the "'168 patent"). The petition challenged all claims of the '168 patent on grounds that...more

Allergan, Inc. v. Apotex, Inc. (Fed. Cir.)

Case Name: Allergan, Inc. v. Apotex, Inc., No. 2013-1245, -1246, -1247, 2014 U.S. App. LEXIS 10710 (Fed. Cir. June 10, 2014) (Circuit Judges Prost, Reyna and Chen presiding; Opinion by Prost, C.J.; Dissent-in-part by Chen,...more

Patent Hold-Up or Patent Hold-Out? Judge Essex Adds His Voice to the SEP-FRAND Debate

Administrative Law Judge Essex recently issued the public version of his Initial Determination in ITC investigation No. 337-TA-868, ruling that the respondents are precluded from relying on the defense that the patent holder...more

Endo Pharms. Inc. v. Actavis, Inc. (Fed Cir)

Case Name: Endo Pharms. Inc. v. Actavis, Inc., Nos. 2013-1658, -1662, 2014 U.S. App. LEXIS 5879 (Fed. Cir. Mar. 31, 2014) (Circuit Judges Newman, Dyk, and Moore presiding; Opinion by Moore, J.; Dissent-in-part by Dyk) (appeal...more

Takeda Pharma. Co. Ltd. v. Zydus Pharmas. USA, Inc. (Fed Cir)

Case Name: Takeda Pharma. Co. Ltd. v. Zydus Pharmas. USA, Inc., No. 2013-1406, 2014 U.S. App. LEXIS 3072 (Fed. Cir. Feb. 20, 2014) (Circuit Judges Prost, Plager, and Chen presiding; Opinion by Prost, J.) (appeal from D.N.J.,...more

Warner Chilcott Co., LLC v. Teva Pharms. USA, Inc.

Case Name: Warner Chilcott Co., LLC v. Teva Pharms. USA, Inc., Case Nos. 08-627-LPS, 11-81-LPS, 09-143-LPS, 10-285-LPS, 2014 U.S. Dist. LEXIS 41865 (D. Del. Mar. 28, 2014) (Stark, J.) - Drug Product and...more

G.D. Searle LLC v. Lupin Pharms, Inc.

Case Name: G.D. Searle LLC v. Lupin Pharms, Inc., Civ. No. 13-cv-121 (E.D. Va. Mar. 12, 2014) (Wright Allen, J.) - Drug Product and Patent(s)-in-Suit: Celebrex® (celecoxib); U.S. Reissue Patent No. 44,048 (“the ’048...more

Classen Immunotherapies, Inc. v. Shionogi, Inc.

Case Name: Classen Immunotherapies, Inc. v. Shionogi, Inc., Civ. No. 13-921-RWT, 2014 U.S. Dist. LEXIS 10642 (D. Md. Jan. 29, 2014) (Titus, J.) - Drug Product and Patent(s)-in-Suit: Computer algorithm and method of...more

Par Pharms., Inc. v. TWi Pharms., Inc.

Case Name: Par Pharms., Inc. v. TWi Pharms., Inc., Civ. No. 11-2466-CCB, 2014 U.S. Dist. LEXIS 21704 (D. Md. Feb. 21, 2014) (Blake, J.) - Drug Product and Patent(s)-in-Suit: Megace ES® (megestrol acetate); U.S. Pat....more

In re Lamictal Direct Purchaser Antitrust Litigation

Case Name: In re Lamictal Direct Purchaser Antitrust Litigation, Case No. 12-cv-995 (WHW), 2014 U.S. Dist. LEXIS 9257 (D.N.J. Jan. 24, 2014) (Walls, J.) - Drug Product and Patent(s)-in-Suit: Lamictal® (lamotrigine);...more

Purdue Pharma L.P. v. Teva Pharms. USA, Inc.

Case Name: Purdue Pharma L.P. v. Teva Pharms. USA, Inc., Civ. Nos. 11-2037-SHS; 12-5083-SHS, 2014 U.S. Dist. LEXIS 5031 (S.D.N.Y. Jan. 14, 2014) (Stein, J.). Drug Product and Patent(s)-in-Suit: OxyContin® (oxycodone);...more

Allergan, Inc. v. Sandoz Inc.

Case Name: Allergan, Inc. v. Sandoz Inc., Case No. 11-cv-441, Dkt. No. 136 (E.D. Tex. Jan. 13, 2014) (Schneider, J.) - Drug Product and Patent(s)-in-Suit: Lumigan® (bimatoprost); U.S. Patents Nos. 7,851,504 (“the ’504...more

Warner Chilcott Co. LLC v. Lupin Ltd.

Case Name: Warner Chilcott Co. LLC v. Lupin Ltd., Civ. Nos. 11-5048, 12-2928, 2014 U.S. Dist. LEXIS 6228 (D.N.J. Jan. 17, 2014) (Pisano, J.). Drug Product and Patent(s)-in-Suit: Lo Loestrin Fe® (norethindrone...more

Declaratory Judgment Action Dismissed for Lack of Personal Jurisdiction Where Contacts in Jurisdiction Occurred Before, and Were...

Digital Ally, Inc. ("Digital Ally") filed a declaratory judgment action pertaining to patent infringement against Utility Associates, Inc. ("Utility"). Utility filed a motion to dismiss for lack of subject matter and personal...more

GENERICally Speaking - Vol. 4, No. 1

The Hatch-Waxman Litigation and Life Sciences practice groups at Robins, Kaplan, Miller & Ciresi L.L.P. are pleased to offer the latest edition of their quarterly publication regarding ANDA patent litigation issues and the...more

Extensive Prior Examination of Patent-In-Suit Justifies Denial of Stay Pending CBM Review before Patent Office

VirtualAgility, Inc. ("VirtualAgility) filed a patent infringement action against Salesforce.com, Inc. ("Salesforce") over a patent purporting to cover processes and tools that provide a common framework for communicating...more

Federal Circuit Affirms ITC Jurisdiction for Non-Practicing Entities

On January 10, 2013, the Federal Circuit reaffirmed broad ITC jurisdiction for non-practicing patent enforcement entities by denying Nokia Corp.’s petition for rehearing of InterDigital Commc’ns, LLC v. Int’l Trade Comm’n...more

20 Results
|
View per page
Page: of 1